Company Filing History:
Years Active: 2013-2018
Title: Marius Keel: Innovator in Sepsis Prediction
Introduction
Marius Keel is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical diagnostics, particularly in the prediction of sepsis in humans. With a total of 2 patents, his work is paving the way for advancements in early detection methods.
Latest Patents
Marius Keel's latest patents focus on a reliable method for assaying sepsis in humans. The first patent describes a method that involves determining the level of pancreatic stone protein/regenerating protein (PSP/reg) in serum. A high level of PSP/reg is indicative of the development of sepsis at early stages of the disease. This innovative approach aims to enhance the prediction of sepsis following trauma, thereby improving patient outcomes.
Career Highlights
Marius Keel is affiliated with the University of Zurich, where he conducts research and develops his inventions. His work is characterized by a commitment to improving medical diagnostics and patient care.
Collaborations
Marius collaborates with esteemed colleagues, including Rolf Graf and Daniel Bimmler. Their combined expertise contributes to the advancement of medical technologies and innovations.
Conclusion
Marius Keel's contributions to the field of sepsis prediction highlight the importance of innovation in medical diagnostics. His patents represent a significant step forward in improving early detection methods for critical health conditions.